Asian Americans are less likely than their white peers to participate in health research involving MRIs and addressing this hesitancy could improve research, according to a Rutgers Health-led study.
Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again, and other thoughts
Thoughts about Cytokinetics after Wednesday night’s financing announcement: 1. Management is raising $500 million at $51 per share, when the stock was at $45 per